SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-023336
Filing Date
2021-05-04
Accepted
2021-05-04 16:10:57
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q2 arwr-10q_20210331.htm   iXBRL 10-Q 2177216
2 EX-31.1 arwr-ex311_13.htm EX-31.1 9855
3 EX-31.2 arwr-ex312_6.htm EX-31.2 10925
4 EX-32.1 arwr-ex321_9.htm EX-32.1 6308
5 EX-32.2 arwr-ex322_11.htm EX-32.2 6557
  Complete submission text file 0001564590-21-023336.txt   6988561

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arwr-20210331.xsd EX-101.SCH 46991
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20210331_cal.xml EX-101.CAL 45511
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20210331_def.xml EX-101.DEF 157492
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20210331_lab.xml EX-101.LAB 386482
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20210331_pre.xml EX-101.PRE 293818
11 EXTRACTED XBRL INSTANCE DOCUMENT arwr-10q_20210331_htm.xml XML 1138711
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 21888539
SIC: 2834 Pharmaceutical Preparations